期刊文献+

中西医结合治疗慢性收缩性心力衰竭临床分析

下载PDF
导出
摘要 目的:探讨中西医结合治疗慢性收缩性心力衰竭的临床效果。方法:将收缩性心力衰竭患者60例平分为治疗组与对照组各30例,两组均给予西医常规治疗,治疗组另予中药黄芪真武汤治疗。结果:经过治疗后,治疗组30例显效13例,有效15例,无效2例,总有效率为93.3%;对照组30例显效6例,有效14例,无效10例,总有效率为66.7%。治疗组的临床疗效明显高于对照组,差异有统计学意义(P<0.05)。两组治疗前心率、收缩压与舒张压比较,差异无统计学意义(P>0.05),经过治疗后,两组心率、收缩压与舒张压都有明显下降(P<0.05),其中治疗组的心率下降幅度更多(P<0.05),而收缩压与舒张压两组治疗后比较,差异无统计学意义(P>0.05)。结论:中西医结合治疗慢性收缩性心力衰竭能提高治疗疗效,改善心率状态,值得推广应用。
作者 翟成玉
出处 《吉林医学》 CAS 2011年第27期5726-5726,共1页 Jilin Medical Journal
  • 相关文献

参考文献2

二级参考文献30

  • 1Tang WHW, Vagelos RH, Yee YG, et al. Neurohormonal and clinical responses to high-versus low-dose enalapril therapy in chronic heart failure. J Am Coll Cardiol,2002,39:70-78.
  • 2CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandanavian enalapril survival study. N Engl J Med, 1987,316:1429-1435.
  • 3Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med, 1996,334:1350-1355.
  • 4Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan comparaed with captopril on mortality in patients with symptomatic heart failure: randomized trial the Losartan Heart Failure Survival Study ELITE-Ⅱ. Lancet, 2000,355:1582-1587.
  • 5Cohn JN. Improveing outcomes in congestive heart failure: Val-HeFT Valsartan in Heart Failure Trial. Cardiology, 1999,91(Suppl 1):19-22.
  • 6Pfeffer MA, McMurray JJ, Velazquez EJ,et al. Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med, 2003,349:1893-1906.
  • 7Pitt B."Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotension converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther, 1995,9:145-149.
  • 8Pitt B, Zannad F,Remme WJ, et al. The effect of spironolactone on morbidity and mortility in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Eng J Med, 1999,341:709-717.
  • 9Packer M, Cohn JN, Abraham WT, et al. Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83(2A):1-38.
  • 10Pitt B, Remme W, Zannad F, et al.For the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med,2003, 348: 1309-1321.

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部